February 14, 2018

Amicus Therapeutics Announces Public Offering of Common Stock

February 12, 2018

U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease

February 7, 2018

Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at 14th Annual WORLDSymposiumâ„¢